Envestnet Asset Management
TARO

Envestnet Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Envestnet Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-64
Closed -$7K – 2738
2018
Q2 		$7K Hold
64
– – ﹤0.01% 2612
2018
Q1 		$6K Hold
64
– – ﹤0.01% 2588
2017
Q4 		$7K Hold
64
– – ﹤0.01% 2702
2017
Q3 		$7K Hold
64
– – ﹤0.01% 2666
2017
Q2 		$7K Hold
64
– – ﹤0.01% 2784
2017
Q1 		$7K Hold
64
– – ﹤0.01% 2854
2016
Q4 		$7K Buy
+64
New +$6.7K ﹤0.01% 2830
2014
Q1 		– Sell
-102
Closed -$10K – 2654
2013
Q4 		$10K Buy
+102
New +$8.85K ﹤0.01% 1762

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Envestnet Asset Management's TARO Position: Q3 2018 in Review

Envestnet Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 64 shares — an estimated $7K sold.

Envestnet Asset Management first reported a position in TARO in Q4 2013 and held it in 8 quarters. The position peaked at $10K in Q4 2013. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

  • Envestnet Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 64 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $7K.
  • Envestnet Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 8 quarters.
  • Envestnet Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $10K in Q4 2013.
  • 114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.